NO20051074L - Forbindelser som kan anvendes til behandlingen av sykdommer som gir respons pa antiangiogenetisk terapi - Google Patents
Forbindelser som kan anvendes til behandlingen av sykdommer som gir respons pa antiangiogenetisk terapiInfo
- Publication number
- NO20051074L NO20051074L NO20051074A NO20051074A NO20051074L NO 20051074 L NO20051074 L NO 20051074L NO 20051074 A NO20051074 A NO 20051074A NO 20051074 A NO20051074 A NO 20051074A NO 20051074 L NO20051074 L NO 20051074L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- diseases
- compounds
- respond
- antiangiogenetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrotherapy Devices (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Denne oppfinnelsen vedrører anvendelsen av bestemte forbindelser til behandling av sykdommer som gir respons på antiangiogenetisk terapi. For mye angiogenese inntrer ved slike sykdommer som kreft, diabetisk blindhet, aldersrelatert makuløs degenerasjon, revmatoid artritt og psoriasis. Forbindelsene er særlig anvendbare til anti-metastatisk behandling eller til behandling av aldersrelatert makuløs degenerasjon.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200201165 | 2002-08-01 | ||
DKPA200201839 | 2002-11-28 | ||
DKPA200300371 | 2003-03-11 | ||
PCT/DK2003/000518 WO2004012733A2 (en) | 2002-08-01 | 2003-07-31 | Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20051074L true NO20051074L (no) | 2005-04-29 |
Family
ID=31498946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051074A NO20051074L (no) | 2002-08-01 | 2005-02-28 | Forbindelser som kan anvendes til behandlingen av sykdommer som gir respons pa antiangiogenetisk terapi |
Country Status (17)
Country | Link |
---|---|
US (1) | US20060058395A1 (no) |
EP (1) | EP1526851B1 (no) |
JP (1) | JP2005537336A (no) |
KR (1) | KR20050026091A (no) |
CN (1) | CN1671378A (no) |
AT (1) | ATE372770T1 (no) |
AU (1) | AU2003260280A1 (no) |
BR (1) | BR0312929A (no) |
CA (1) | CA2493253A1 (no) |
DE (1) | DE60316297T2 (no) |
IL (1) | IL166040A0 (no) |
IS (1) | IS7723A (no) |
MX (1) | MXPA05001235A (no) |
NO (1) | NO20051074L (no) |
NZ (1) | NZ537809A (no) |
PL (1) | PL375318A1 (no) |
WO (1) | WO2004012733A2 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004017175D1 (de) | 2003-06-17 | 2008-11-27 | Neurosearch As | Diphenylurea-derivative und ihre verwendung als chloridkanalblocker |
US7550499B2 (en) | 2004-05-12 | 2009-06-23 | Bristol-Myers Squibb Company | Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
MX2007008434A (es) | 2005-01-19 | 2007-07-25 | Squibb Bristol Myers Co | Derivados de 2-fenoxi-n-(1,3,4-tiadizol-2il)piridin-3-amina y compuestos relacionados como inhibidores del receptor p2y1 para el tratamiento de trastornos tromboembolicos. |
WO2006085302A2 (en) * | 2005-02-08 | 2006-08-17 | Bmz Diagnosis (2004) Ltd. | Composition for treatment of skin disorders |
DE602006017694D1 (de) | 2005-06-27 | 2010-12-02 | Bristol Myers Squibb Co | C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden |
WO2007002634A1 (en) | 2005-06-27 | 2007-01-04 | Bristol-Myers Squibb Company | Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
KR20080027890A (ko) | 2005-06-27 | 2008-03-28 | 브리스톨-마이어스 스큅 컴퍼니 | 혈전성 증상의 치료에 유용한 p2y1 수용체의 n-연결헤테로시클릭 길항제 |
ATE502924T1 (de) | 2005-06-27 | 2011-04-15 | Bristol Myers Squibb Co | Lineare harnstoffmimetika-antagonisten des p2y1- rezeptors zur behandlung von thromboseleiden |
US7960569B2 (en) | 2006-10-17 | 2011-06-14 | Bristol-Myers Squibb Company | Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
US20110110958A1 (en) * | 2007-09-11 | 2011-05-12 | University Of Florida Research Foundation | Compositions and methods for the treatment of neoplasia |
WO2016001452A1 (en) * | 2014-07-04 | 2016-01-07 | Universität Zürich | Compounds, in particular for use in the treatment of a disease or condition for which a bromodomain inhibitor is indicated |
EP3458052B1 (en) | 2016-05-17 | 2019-11-06 | Scandion Oncology A/S | Combination treatment of cancer |
EP3846802A1 (en) * | 2018-09-06 | 2021-07-14 | Scandion Oncology A/S | Urea derivatives for use in the treatment of subjects with elevated expression and/or activity of srpk1 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0809492A4 (en) * | 1995-02-17 | 2007-01-24 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
WO1998047879A1 (en) * | 1997-04-22 | 1998-10-29 | Neurosearch A/S | Substituted phenyl derivatives, their preparation and use |
WO1999032436A1 (en) * | 1997-12-22 | 1999-07-01 | Bayer Corporation | Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
AP2001002103A0 (en) * | 1998-10-22 | 2001-03-31 | Neurosearch As | Substituted phenyl derivatives, their preparation and use. |
CO5200760A1 (es) * | 1999-06-16 | 2002-09-27 | Smithkline Beecham Corp | Antagonistas del receptor de la il-8 ceptor il-8 |
BR0312503A (pt) * | 2002-07-09 | 2007-06-26 | Bristol Myers Squibb Co | derivados heterocìclicos substituìdos úteis como agentes antidiabéticos e antiobesidade, composição farmacêutica, uso e combinação dos mesmos |
-
2003
- 2003-07-31 US US10/522,258 patent/US20060058395A1/en not_active Abandoned
- 2003-07-31 KR KR1020057001801A patent/KR20050026091A/ko not_active Application Discontinuation
- 2003-07-31 CA CA002493253A patent/CA2493253A1/en not_active Abandoned
- 2003-07-31 AU AU2003260280A patent/AU2003260280A1/en not_active Abandoned
- 2003-07-31 IL IL16604003A patent/IL166040A0/xx unknown
- 2003-07-31 JP JP2005505653A patent/JP2005537336A/ja not_active Withdrawn
- 2003-07-31 DE DE60316297T patent/DE60316297T2/de not_active Expired - Lifetime
- 2003-07-31 EP EP03766118A patent/EP1526851B1/en not_active Expired - Lifetime
- 2003-07-31 WO PCT/DK2003/000518 patent/WO2004012733A2/en active IP Right Grant
- 2003-07-31 CN CNA038183730A patent/CN1671378A/zh active Pending
- 2003-07-31 PL PL03375318A patent/PL375318A1/xx not_active Application Discontinuation
- 2003-07-31 NZ NZ537809A patent/NZ537809A/en unknown
- 2003-07-31 AT AT03766118T patent/ATE372770T1/de not_active IP Right Cessation
- 2003-07-31 BR BR0312929-2A patent/BR0312929A/pt not_active IP Right Cessation
- 2003-07-31 MX MXPA05001235A patent/MXPA05001235A/es unknown
-
2005
- 2005-02-28 NO NO20051074A patent/NO20051074L/no unknown
- 2005-03-01 IS IS7723A patent/IS7723A/is unknown
Also Published As
Publication number | Publication date |
---|---|
IL166040A0 (en) | 2006-01-15 |
WO2004012733A9 (en) | 2005-03-10 |
DE60316297T2 (de) | 2008-06-19 |
ATE372770T1 (de) | 2007-09-15 |
US20060058395A1 (en) | 2006-03-16 |
CA2493253A1 (en) | 2004-02-12 |
EP1526851A2 (en) | 2005-05-04 |
IS7723A (is) | 2005-03-01 |
NZ537809A (en) | 2007-05-31 |
MXPA05001235A (es) | 2005-06-08 |
CN1671378A (zh) | 2005-09-21 |
EP1526851B1 (en) | 2007-09-12 |
WO2004012733A2 (en) | 2004-02-12 |
WO2004012733A3 (en) | 2004-03-18 |
BR0312929A (pt) | 2005-07-12 |
DE60316297D1 (de) | 2007-10-25 |
AU2003260280A1 (en) | 2004-02-23 |
PL375318A1 (en) | 2005-11-28 |
JP2005537336A (ja) | 2005-12-08 |
KR20050026091A (ko) | 2005-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051074L (no) | Forbindelser som kan anvendes til behandlingen av sykdommer som gir respons pa antiangiogenetisk terapi | |
MX2021014007A (es) | Proteinas de union a epcam y metodos de uso. | |
NO20062876L (no) | Sammensetninger til kombinert radio- og kjemoterapi, og fremgangsmater | |
TW200736231A (en) | Substituted pyrimidines | |
NO20051451L (no) | Pyrimidinderivater og deres anvendelse som CB2 modulatorer | |
EA202091709A1 (ru) | Ингибиторы днк-пк | |
NO20055832L (no) | Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme | |
NO20075849L (no) | Fremgangsmater og preparater til behandling eller forebygging av kreft | |
AU2003220970A1 (en) | Diamino-pyrimidines and their use as angiogenesis inhibitors | |
NO20060230L (no) | Nye aminobenzofenonforbindelser | |
NO20084396L (no) | Kombinasjonsterapi | |
NO20070782L (no) | Tetrapeptidanaloger. | |
MX2010005651A (es) | Inhibicion de receptor de proteina de estimulacion de macrofagos (ron) y sus metodos de tratamiento. | |
CR7043A (es) | Derivados de eteres utiles como ganetes inhibidores de las isozimas pde4 | |
WO2006121610A3 (en) | Personal care compositions and methods for their use | |
WO2007065010A3 (en) | Anti-angiogenesis compounds | |
DE60318198D1 (de) | Tyrosinkinase-hemmer | |
MX2018016419A (es) | Derivados de n-(sustituida-fenil)-sulfonamida como inhibidores de quinasa n-(sustituida-fenil)-sulfonamida. | |
WO2006128455A3 (en) | Compounds modifying apoptosis | |
WO2007076085A3 (en) | Fused pyrimidones and thiopyrimidones, and uses thereof | |
NO20073981L (no) | Criptobindende molekyler | |
NO20052028L (no) | Pyridinderivater som CB2 reseptor modulatorer | |
NO20063196L (no) | Nye fusjonerte pyrrolokarbazoler | |
WO2005023202A3 (en) | Tumor suppressor lkb1 kinase directly activates amp-activated kinase | |
MX2022010175A (es) | Proteinas de union a flt3 y metodos de uso. |